BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around...(ve and safest antimicrobial known. This ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
Date:8/19/2008
ve and safest antimicrobial known. This class of products has important applications for consumers, health care and the military. ChemoNeutralizers irreversibly bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.
Visit http://www.bioneutrallabs.com to view the interview with Dr. Philip Tierno.
About Dr. Philip Tierno
Dr. Tierno is a consultant to BioNeutral. He is the Director of
Clinical Microbiology and Diagnostic Immunology at Langone NYU Medical
Center. He is also an Associate Professor at the New York University School
of Medicine, NYU College of Dentistry and SUNY School of Optometry in New
York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve
Corps) and a former member of New York City's task force on bioterrorism.
Dr. Tierno's work in the field of microbiology has resulted in numerous
articles and texts that have been published in medical and scientific
journals. He is co-editor and author of several books on microbes and
biological protection.
Contact Information:
BioNeutral Laboratories Corporation USA
http://www.bioneutralgroup.com
Dr. Andy Kielbania
Chief Scientist
Stephen J. Browand
Director
Governmental Affairs
Dr. Philip Tierno
Consultant
This release was issued through eReleases(TM). For more i
'/>"/>
| SOURCE BioNeutral Laboratories Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
2. Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide
3. St. Lukes Episcopal Hospital to Add CyberKnife System to Treatment Offerings
4. FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia
5. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
6. U.S. News Media Group Releases 19th Edition of Americas Best Hospitals
7. Isabel Healthcare Adds Hospitals in Wisconsin & Minnesota
8. Low-Power Ultra Wideband (UWB) Technology Best RFID Choice for Hospitals to Minimize Interference Threat
9. Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point
10. Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point
11. Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007
Post Your Comments:
(Date:11/20/2009)..., , STOCKHOLM, November 20 /PRNewsw...that the European Investment Fund (EIF) has entere... The co-investment fund will be,managed by Karolin...s,portfolio of early-stage pharmaceutical and medi... 26.7 M Euros in the co-investment fund. The agree...
(Date:11/19/2009)... , Most people would like to be able to charge th...ckly and not too often. A recent discovery made by...ube-based supercapacitors that could do just this....ysics Letters , Prabhakar Bandaru, a professor in ...gineering, along with graduate student Mark Hoefer...
(Date:11/19/2009)..., , ,, BETHESDA, Md., Nov. 19 /PRN...: SPEX ), an innovator in biotechnology for diabe...atory consulting services to food, supplement, bio... today it closed the previously reported $6.3 mill...nvestors of 2,760,870 shares of its common stock a...
(Date:11/19/2009)..., , MUNSTER, Germany, November 19 /P... they have filed on November 16th, 2009 Flibanseri...duced dyskinesia in Parkinson,s,disease for orphan...es Agency,(EMEA). Levodopa-induced dyskinesia is a...d Parkinson,s and a serious burden to some of thos...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2[0] Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation[0] Nanotube defects equal better energy and storage systems[0] Spherix Announces the Closing of $6.3 Million Registered Direct Offering[0] MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"
...ics, Inc. (Nasdaq: OREX ), a biopharmaceutical c...announced that the Company will be speaking at the...orum, Date: Tuesday, May 19, 2009, Time: 9...a World Congress Center, Room 316, Atlanta, Georgi...ent, Medical Affairs and, Communicati...
...iard Pharmaceuticals, Inc. (Nasdaq: PARD ), a bi...logy therapies, today announced that Jerry McMahon...l provide a corporate overview at the Leerink Swan... 20, at 2:00 p.m. Eastern Time in New York. , ,... a discussion about the clinical development progr...
...a visualization and search augments Cognos BI for ... decision-making , Orland...sual-io.com ) today announced and unveiled the new...ractive visual analysis and business intelligence...ognosforum/ ), taking place in Orlando, FL---May 1...
Other Biology Technology:Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference 2Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software 2Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software 3Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software 4(Date:11/20/2009)...c obstructive pulmonary disease (COPD), a respirat...r emphysema, is the fourth leading cause of death ...while researchers have yet to find any real treatm...titute at The University of Western Ontario in Lon...o gain new insight into the disease. , Parra...
(Date:11/19/2009)... naturally occurring brain chemical with an unwiel... it can be abused or used as a date-rape drug. ,... determined new routes by which 4-HB is metabolize...ion," said K. Michael Gibson, professor and chair ...niversity and a member of the research team. "It ...
(Date:11/19/2009)...N This week, scientists are revealing the genetic...real crops. Corn, or maize, has one of the most co...ity of Wisconsin-Madison genomicist David Schwartz...cle in the journal Science . , "The maize genom...ad-ends that have troubled would-be sequencers for...
Breaking Biology News(10 mins):Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Cellu Tissue Holdings Inc Files Registration Statement for Proposed Initial Public Offering of Common Stock 14515 1Cellu Tissue Holdings Inc Files Registration Statement for Proposed Initial Public Offering of Common Stock 14515 2National Science Foundation awards grant to Oklahoma structural biology group 10403 1Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies 5543 1Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies 5543 2...ular signals that instructs cells with fatally dam...suppressor gene. If p53 is inactivated, as it is i...ces on cell growth fail to operate, and body cells...ay lead to cancer. Not surprisingly, the regulatio...t detail for many years but mainly in tissue cultu...
...ancer drug can survive an otherwise lethal dose of...ort scientists supported by the National Institute...of the National Institutes of Health. The findings...imilar drugs might be useful in preventing adverse...llpox vaccine is made from live, weakened vaccinia...
... the University of California, Berkeley, and the H...g cleaner, more efficient technologies for produci...nd have significant climate change and development...y developing nations in Asia and Latin America, is...nd heating homes. In 2000, nearly 470 million tons...
Other Biology News:Cancer related gene p53 not regulated as indicated by previous tissue culture research 2Cancer related gene p53 not regulated as indicated by previous tissue culture research 3Cancer drug slows poxvirus in mice 2Cancer drug slows poxvirus in mice 3Study of energy and health in Africa focuses spotlight on charcoal and forest management 2Study of energy and health in Africa focuses spotlight on charcoal and forest management 3Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
Baker's yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
S-Protein Agarose from Novagen
ATX Ponceau S red staining solution from Sigma-Aldrich
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |